Background This study examined changes in cognitive-functional relationships in vascular dementia (VaD) over the course of one year. Methods Twenty-four patients with probable VaD were administered the Dementia Rating Scale (DRS). Caregivers completed an informant-based measure of instrumental (IADL) and basic activities of daily living (BADL). Follow-up assessment was conducted one-year post-baseline. Results Logistic regression revealed that changes in the DRS Initiation/Perseveration and DRS Memory subscales were significantly associated with declines in IADLs and BADLs, respectively. Conclusions Among patients with VaD, longitudinal changes in IADLs and BADLs are most strongly associated with changes in executive functioning and memory abilities, respectively. Findings suggest that different cognitive functions subserve complex instrumental and rote, habituated basic functional activities, and neuropsychological screening measures are useful in the prediction of such functional changes.
Impairment in instrumental activities of daily living (IADLs) or basic activities of daily living (BADLs) is an essential feature for a dementia diagnosis. Elucidating the cognitive predictors of functional decline is an important research endeavor, as clinicians are frequently involved in prognostic determinations regarding patients' personal independence and safety. Such information would be invaluable in cases where patients lack direct care providers.
Cognitive-functional relationships have been examined in cross-sectional studies of Alzheimer's disease (AD), with executive dysfunction as a significant correlate (Boyle et al., 2003) . Cognitive-functional relationships have received less attention in vascular dementia (VaD), despite its prevalence. A better understanding of longitudinal functional decline is needed, particularly with regard to the identification of dementia screening predictors of functional change.
METHODS
This is a longitudinal study of cognitive capacity and functional decline in 36 patients with VaD. Participants included 18 women and 18 men enrolled in a 12-month, double-blind, placebo-controlled pharmacologic trial of citicoline for the treatment of VaD (18 ¼ drug, 18 ¼ placebo). Pharmacologic trial findings revealed no significant drug effect on cognitive or functional outcomes . Due to attrition, one-year follow-up data is based on 24 individuals (placebo ¼ 12, citicoline ¼ 12).
Probable VaD diagnoses were made by clinical neurologists according to NINDS/AIREN and DSM-IV criteria. Inclusion criteria required that participants were age 55 or older with MMSE scores ranging 9-24. Exclusion criteria included current terminal systemic disease, unstable medical condition, other neurological disorder (e.g. Alzheimer's disease), or major psychiatric disturbance. The following assessments were performed at baseline and one-year later:
Dementia rating scale (DRS; Mattis, 1973) The DRS provides an estimate of global cognitive functioning tapping five cognitive areas: Attention (ATT): auditory-visual and verbal-nonverbal attention; Initiation/Perseveration (I/P): initiation, switching, and termination of cognitive activities; Conceptualization (CONCEPT): verbal and nonverbal abstraction; Construction (CONSTR): visuoperception and reproduction of geometric designs; Memory (MEM): verbal and nonverbal recall and recognition.
Instrumental activities of daily living & physical self-maintenance scale (IADL-PSMS)
The IADL-PSMS is an informant-based measure of IADLs (shopping, housekeeping/maintenance, cooking, driving, finances, medication management, telephone use, laundry) and BADLs (bathing, grooming, dressing, feeding, toileting, physical ambulation). Scoring is based on performance needs (i.e., dependence, requires assistance, independence).
Procedures
The study was approved by the local IRB, and informed consent was obtained from all participants and primary caregivers. Procedures were identical at baseline and 12-month assessment. Cognitive measures were administered by a trained psychometrician, while primary caregivers completed the IADL-PSMS.
RESULTS
Demographic characteristics are presented in Table 1 . No significant differences were observed between participants retained versus those lost to attrition for baseline age (F (1,35) ¼ 0.26, ns), education (F (1,35) ¼2.10, ns), DRS total (F (1,35) ¼ 1.20, ns), IADLs (F (1,34) ¼ 0.96, ns), or BADLs (F (1,34) ¼ 1.23, ns).
To balance predictive capability with model parsimony and account for multicollinearity, a stepwise logistic regression procedure was used to assess the contribution of five cognitive change scores to the IADL and BADL change scores. IADL and BADL change scores were each recoded into dichotomous variables for the analysis (i.e. decline vs no decline). Both forward and backward stepwise procedures, using a likelihood ratio criterion for variable addition/deletion, selected a model with I/P change as the single significant predictor of IADL change (beta ¼ 0.25, p ¼ 0.03) and MEM change as the single significant predictor of BADL change (beta ¼ 0.61, p ¼ 0.03). (Boyle et al., 2003; Cahn-Weiner et al., 2003) and memory to BADLs (Drachman et al., 1990) and augment the cognitive-functional literature by demonstrating that such relationships maintained in VaD.
The current study is limited by a small sample and brief follow-up period. Future studies should include larger samples and follow patients for several years. Inclusion of mild cognitive impairment participants with a suspected vascular etiology may help identify early functional compromises.
Our study highlights the importance of longitudinally assessing cognitive-functional relationships in dementia as well as the relevance of using neuropsychological screening measures in the prediction of functional changes. Such information has clinical significance, as changes in executive functioning and memory appear to have the strongest relationship to changes in IADLs and BADLs, respectively.
